Related Experiment Video
Updated: May 16, 2026

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Ferrous iron-dependent delivery of therapeutic agents to the malaria parasite
Sumit S Mahajan1, Jiri Gut, Philip J Rosenthal
1Small Molecule Discovery Center, Department of Pharmaceutical Chemistry, University of California, San Francisco, Byers Hall 503D, 1700 4th Street, San Francisco, CA 94158, USA.
Background:
The malaria parasites Plasmodium falciparum and Plasmodium vivax generate significant concentrations of free unbound ferrous iron heme as a side product of hemoglobin degradation. The presence of these chemically reactive forms of iron, rare in healthy cells, presents an opportunity for parasite-selective drug delivery. Accordingly, our group is developing technologies for the targeted delivery of therapeutics to the intra-erythrocytic malaria parasite. These so-called 'fragmenting hybrids' employ a 1,2,4-trioxolane ring system as an iron(II)-sensing 'trigger' moiety and a 'traceless' retro-Michael linker to which a variety of partner drug species may be attached. After ferrous iron-promoted activation in the parasite, the partner drug is released via a β-elimination reaction.
Methods:
In this report, we describe three orthogonal experimental approaches that were explored in order to generate in vitro proof-of-concept for ferrous iron-dependent drug delivery from a prototypical fragmenting hybrid.
Conclusion:
Studies of two fragmenting hybrids by orthogonal approaches confirm that a partner drug species can be delivered to live P. falciparum parasites. A key advantage of this approach is the potential to mask a partner drug's intrinsic bioactivity prior to release in the parasite.
Insights
Researchers developed novel 'fragmenting hybrids' for targeted malaria drug delivery. These compounds release drugs selectively inside Plasmodium parasites, triggered by iron, enhancing treatment efficacy.
Area of Science:
- Medicinal Chemistry
- Parasitology
- Drug Delivery Systems
Background:
- Malaria parasites (Plasmodium falciparum, Plasmodium vivax) produce toxic free iron heme during hemoglobin digestion.
- This parasite-specific iron accumulation presents a unique target for selective drug delivery.
- Current drug development focuses on intra-erythrocytic parasite targeting.
Purpose of the Study:
- To develop and validate a novel drug delivery system for malaria parasites.
- To demonstrate parasite-selective drug release triggered by ferrous iron.
- To create 'fragmenting hybrids' for targeted therapeutic delivery.
Main Methods:
- Development of 'fragmenting hybrids' incorporating a 1,2,4-trioxolane iron(II)-sensing trigger.
- Utilizing a 'traceless' retro-Michael linker for drug attachment.
- Employing three orthogonal experimental approaches for in vitro proof-of-concept validation.
Main Results:
- Successful in vitro proof-of-concept for ferrous iron-dependent drug delivery was achieved.
- Two fragmenting hybrids demonstrated effective partner drug delivery to live P. falciparum parasites.
- The system successfully masked partner drug bioactivity until release within the parasite.
Conclusions:
- Fragmenting hybrids enable targeted drug delivery to intra-erythrocytic malaria parasites.
- Ferrous iron-triggered release mechanism proves effective for parasite-selective therapy.
- This approach offers a strategy to mask drug activity, improving therapeutic index.
Related Concept Videos
The Early Endosome: Endocytosis of Transferrin
Anthelminthic Agents
Microbes and Other Elemental Cycles
Modified-Release Drug Delivery Systems: Site-Targeted
Symbiosis

